nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Author’s Response
|
Rao, Niranjan |
|
2011 |
51 |
5 |
p. 784-784 |
artikel |
2 |
Biliary Excretion of Ximelagatran and Its Metabolites and the Influence of Erythromycin Following Intraintestinal Administration to Healthy Volunteers
|
Matsson, Elin M. |
|
2011 |
51 |
5 |
p. 770-783 |
artikel |
3 |
Effect of Antipsychotic Medications on Glucose and Lipid Levels
|
Chaggar, Parminder S. |
|
2011 |
51 |
5 |
p. 631-638 |
artikel |
4 |
Effect of Citrus Juice and SLCO2B1 Genotype on the Pharmacokinetics of Montelukast
|
Mougey, E. B. |
|
2011 |
51 |
5 |
p. 751-760 |
artikel |
5 |
Effect of Hepatic or Renal Impairment on Eltrombopag Pharmacokinetics
|
Bauman, John W. |
|
2011 |
51 |
5 |
p. 739-750 |
artikel |
6 |
Effects of Food on the Pharmacokinetics of Edoxaban, an Oral Direct Factor Xa Inhibitor, in Healthy Volunteers
|
Mendell, Jeanne |
|
2011 |
51 |
5 |
p. 687-694 |
artikel |
7 |
Evaluation of Single-Point Sampling Strategies for the Estimation of Moclobemide Exposure in Depressive Patients
|
Ignjatovic, Anita Rakic |
|
2011 |
51 |
5 |
p. 661-671 |
artikel |
8 |
In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects
|
Shoaf, Susan E. |
|
2011 |
51 |
5 |
p. 761-769 |
artikel |
9 |
Modeling Dropout From Adverse Event Data: Impact of Dosing Regimens Across Pregabalin Trials in the Treatment of Generalized Anxiety Disorder
|
Lalovic, Bojan |
|
2011 |
51 |
5 |
p. 706-718 |
artikel |
10 |
Optimizing Drug Development and Use in Patients With Kidney Disease
|
Nolin, Thomas D. |
|
2011 |
51 |
5 |
p. 628-630 |
artikel |
11 |
Pharmacokinetics of 5-Aminofluorescein-Albumin, a Novel Fluorescence Marker of Brain Tumors During Surgery
|
Ding, Reinhard |
|
2011 |
51 |
5 |
p. 672-678 |
artikel |
12 |
Pharmacokinetics of Clofarabine in Patients With High-Risk Inherited Metabolic Disorders Undergoing Brain-Sparing Hematopoietic Cell Transplantation
|
Long-Boyle, Janel |
|
2011 |
51 |
5 |
p. 679-686 |
artikel |
13 |
Pharmacokinetics of Dexrazoxane in Subjects With Impaired Kidney Function
|
Brier, Michael E. |
|
2011 |
51 |
5 |
p. 731-738 |
artikel |
14 |
Population Approach for Exposure-Response Modeling of Golimumab in Patients With Rheumatoid Arthritis
|
Hu, Chuanpu |
|
2011 |
51 |
5 |
p. 639-648 |
artikel |
15 |
Safety, Pharmacokinetic, and Pharmacodynamic Evaluations of PI-2301, a Potent Immunomodulator, in a First-in-Human, Single-Ascending-Dose Study in Healthy Volunteers
|
Kovalchin, Joseph |
|
2011 |
51 |
5 |
p. 649-660 |
artikel |
16 |
Safety, Tolerability, and Pharmacokinetics of Eliglustat Tartrate (Genz-112638) After Single Doses, Multiple Doses, and Food in Healthy Volunteers
|
Peterschmitt, M. Judith |
|
2011 |
51 |
5 |
p. 695-705 |
artikel |
17 |
Skin Cleansers: The Risks of Chlorhexidine
|
Sivathasan, Niroshan |
|
2011 |
51 |
5 |
p. 785-786 |
artikel |
18 |
The Intravenous Anesthetic Propofol Inhibits Human L-Type Calcium Channels by Enhancing Voltage-Dependent Inactivation
|
Fassl, Jens |
|
2011 |
51 |
5 |
p. 719-730 |
artikel |